Repaglinide Tablets 2 mg are an oral antidiabetic drug belonging to the meglitinide class.
It stimulates insulin release from pancreatic beta cells by closing ATP-dependent potassium channels, leading to rapid and short-lived insulin secretion that effectively controls postprandial blood glucose elevation.
Composition
Each film‑coated tablet contains:
Repaglinide …… 2 mg
Indications
Treatment of type 2 diabetes mellitus in adults when diet, exercise, and weight reduction alone do not provide adequate glycemic control.
May be used as monotherapy or in combination with metformin or other antidiabetic agents.
Key Features
Short-acting, rapid onset of action
Specifically targets postprandial hyperglycemia
Flexible dosing regimen taken before main meals
Lower risk of prolonged hypoglycemia compared to some sulfonylureas
Well-tolerated in most patients
Manufactured under strict GMP standards
Complies with EP / USP / CP pharmacopoeial standards
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
Important Note
Prescription-only medicine
Contraindicated in patients with hypersensitivity to repaglinide
Caution in patients with hepatic or moderate to severe renal impairment
Risk of hypoglycemia; avoid skipping meals after dosing
Use under medical supervision
